Everbright Health

Based in the US, Everbright Health specializes in enhancing mental health treatment by integrating advanced FDA-approved interventions into healthcare practices, allowing providers to offer cutting-edge solutions to patients efficiently. Everbright Health is focused on improving mental health care delivery by embedding advanced treatment options into existing healthcare frameworks. Headquartered in San Francisco, US, the company has recently raised USD 7. 00 mn in Seed funding from investors including W Health Ventures and Sanos Capital, marking a pivotal step in their growth strategy.

Founded by a team with deep expertise in healthcare innovation, the company has maintained its original mission without major pivots in strategy. The latest funding round was completed on October 14, 2025, marking the total amount raised since inception at USD 7. 00 mn. Everbright Health specializes in integrating advanced, FDA-approved mental health interventions into existing medical practices, enhancing patient care while streamlining operations for healthcare providers.

Their core offerings include Transcranial Magnetic Stimulation (TMS) and SPRAVATO® (esketamine), which address treatment-resistant mental health conditions. This model allows healthcare practices to provide innovative solutions without significant upfront investment, supporting practices across the United States. Everbright Health operates a revenue model centered on partnerships with healthcare practices, facilitating the introduction of advanced mental health services. The company manages the entire service line, which includes securing patient activation, billing, compliance, and prior authorizations.

Revenue is generated through the integration and management of advanced interventions, typically structured as a share of the profits realized through these enhanced offerings, aligning financial interests with practice partners. In October 2025, Everbright Health raised USD 7. 00 mn in Seed funding to expand its mental health treatments. The company plans to use this funding to build clinical infrastructure, deploy its tech platform, and manage operations for provider partners across multiple markets.

The initiative will support expansion into new geographic regions, allowing Everbright to enhance its service provision while addressing the growing demand for effective mental health solutions.